| Primary |
| Drug Use For Unknown Indication |
29.5% |
| Product Used For Unknown Indication |
11.8% |
| Erysipelas |
6.8% |
| Bronchitis |
5.8% |
| Nasopharyngitis |
5.6% |
| Tooth Extraction |
4.3% |
| Urinary Tract Infection |
3.6% |
| Prophylaxis |
3.4% |
| Toothache |
3.4% |
| Dental Care |
3.0% |
| Endocarditis |
3.0% |
| Tonsillitis |
2.8% |
| Bacterial Infection |
2.4% |
| Pyelonephritis |
2.4% |
| Helicobacter Infection |
2.1% |
| Hypertension |
2.1% |
| Infection |
2.1% |
| Tooth Abscess |
2.1% |
| Cough |
1.9% |
| Infective Myositis |
1.9% |
|
| Urticaria |
14.8% |
| Toxic Skin Eruption |
13.8% |
| Vomiting |
11.1% |
| Pruritus |
6.3% |
| Renal Failure Acute |
6.3% |
| Rash |
4.8% |
| Rash Maculo-papular |
4.8% |
| Thrombocytopenia |
4.8% |
| Pyrexia |
4.2% |
| Rash Macular |
3.7% |
| Urticaria Generalised |
3.7% |
| Hepatocellular Injury |
3.2% |
| Skin Exfoliation |
3.2% |
| Skin Lesion |
2.6% |
| Urinary Tract Infection |
2.6% |
| Neutropenia |
2.1% |
| Renal Failure |
2.1% |
| Tachycardia |
2.1% |
| Transaminases Increased |
2.1% |
| Diarrhoea |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
23.5% |
| Bipolar I Disorder |
12.6% |
| Drug Use For Unknown Indication |
9.5% |
| Helicobacter Infection |
5.7% |
| Toothache |
4.5% |
| Urinary Tract Infection |
4.3% |
| Pyelonephritis |
4.1% |
| Pain |
3.9% |
| Prophylaxis |
3.9% |
| Hypertension |
3.7% |
| Osteitis |
3.0% |
| Duodenal Ulcer |
2.8% |
| Hiv Infection |
2.6% |
| Anaesthesia |
2.4% |
| Head Injury |
2.4% |
| Procedural Pain |
2.4% |
| Pyrexia |
2.4% |
| Plasma Cell Myeloma |
2.2% |
| Bacterial Infection |
2.0% |
| Bronchitis |
2.0% |
|
| Toxic Skin Eruption |
13.7% |
| Rash |
8.4% |
| Renal Failure Acute |
8.4% |
| Neutropenia |
7.4% |
| Henoch-schonlein Purpura |
5.3% |
| Rash Maculo-papular |
5.3% |
| Thrombocytopenia |
5.3% |
| Hepatitis Cholestatic |
4.2% |
| Renal Failure |
4.2% |
| Skin Exfoliation |
4.2% |
| Tubulointerstitial Nephritis |
4.2% |
| Vomiting |
4.2% |
| Acute Generalised Exanthematous Pustulosis |
3.2% |
| Agranulocytosis |
3.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.2% |
| Pyrexia |
3.2% |
| Shock Haemorrhagic |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Urticaria |
3.2% |
| Vascular Purpura |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.7% |
| Product Used For Unknown Indication |
16.0% |
| Unevaluable Event |
11.8% |
| Prophylaxis |
8.2% |
| Hiv Infection |
4.7% |
| Plasma Cell Myeloma |
4.4% |
| Sepsis |
4.4% |
| Antiviral Treatment |
3.5% |
| Hypertension |
3.1% |
| Crohn's Disease |
2.8% |
| Pain |
2.3% |
| Antiviral Prophylaxis |
2.1% |
| Erysipelas |
2.0% |
| Helicobacter Infection |
2.0% |
| Osteitis |
2.0% |
| Pneumonia Streptococcal |
2.0% |
| Diabetes Mellitus |
1.9% |
| Endocarditis |
1.7% |
| Diverticulum |
1.6% |
| Metastases To Peritoneum |
1.6% |
|
| Renal Failure Acute |
16.3% |
| Weight Decreased |
9.2% |
| Pyrexia |
8.2% |
| Toxic Skin Eruption |
8.2% |
| Vomiting |
7.1% |
| Thrombocytopenia |
6.1% |
| Pneumonia |
5.1% |
| General Physical Health Deterioration |
4.1% |
| Renal Failure |
4.1% |
| Sepsis |
4.1% |
| Eosinophilic Pneumonia |
3.1% |
| Melaena |
3.1% |
| Pseudomonal Sepsis |
3.1% |
| Rash Papular |
3.1% |
| Septic Shock |
3.1% |
| Somnolence |
3.1% |
| Transaminases Increased |
3.1% |
| Coma |
2.0% |
| Diarrhoea |
2.0% |
| Drug Exposure During Pregnancy |
2.0% |
|
| Interacting |
| Atrial Fibrillation |
16.1% |
| Urinary Tract Infection |
12.9% |
| Bacterial Pyelonephritis |
6.5% |
| Escherichia Infection |
6.5% |
| Helicobacter Infection |
6.5% |
| Nephrotic Syndrome |
6.5% |
| Prophylaxis |
6.5% |
| Type 1 Diabetes Mellitus |
6.5% |
| Antibiotic Prophylaxis |
3.2% |
| Arrhythmia |
3.2% |
| Arrhythmia Supraventricular |
3.2% |
| Bronchitis |
3.2% |
| Cardiomyopathy |
3.2% |
| Coagulopathy |
3.2% |
| Gastroenteritis Salmonella |
3.2% |
| Oesophageal Candidiasis |
3.2% |
| Pain |
3.2% |
| Thrombosis Prophylaxis |
3.2% |
|
| International Normalised Ratio Increased |
30.0% |
| Subcutaneous Haematoma |
20.0% |
| Haematoma |
10.0% |
| Muscle Haemorrhage |
10.0% |
| Renal Haemorrhage |
10.0% |
| Subdural Haematoma |
10.0% |
| Upper Gastrointestinal Haemorrhage |
10.0% |
|
